Figure 6. Clinical Outcomes.
Panel A shows Kaplan–Meier estimates of overall survival among patients with LGGs that are classified according to traditional histologic type and grade. GBM samples (from previously published Cancer Genome Atlas data22) are also included for comparison. Panel B shows overall survival among patients with LGGs that are classified according to IDH mutation and 1p/19q codeletion status. GBM samples classified according to IDH mutation status are also included. The results of an age-adjusted analysis are provided in Table S2 in Supplementary Appendix 1, and further division according to histologic type, grade, and molecular subtype is shown in Fig. S22 in Supplementary Appendix 1.